openPR Logo
Press release

Ventricular Assist Devices Market Trend and Demands 2019 with Key Players: Terumo Medical Corporation, Medtronic, Abiomed, LivaNova

01-04-2019 12:28 PM CET | Health & Medicine

Press release from: Global Market Insights

Ventricular Assist Devices Market

Ventricular Assist Devices Market

Global Ventricular assist devices market is set to exceed USD 2.0 billion by 2024; according to a new research study published by Global Market Insights, Inc.

Recent technological advancements in the design and functioning of ventricular assist devices making it more efficient, risk-free and less invasive will lead to growing demand and adoption rate of the device. Improvements in the devices and the implantation procedures has reduced the health risk and increased the survival rate in patients. These rapid technological advancements will be one of the major factors for boosting the market growth in the near future.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3014

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Terumo Medical Corporation
• Medtronic
• Abiomed
• LivaNova
• Berlin Heart GmbH
• BiVACOR Inc
• Cardiobridge GmbH
• Cardiokinetix
• Evaheart, Inc.
• Maquet Getinge Group
• HeartWare Inc
• ReliantHeart Inc.
• SynCardia Systems, LLC
• Kalila Medical (Abbott Laboratories)

Left ventricular assist devices market held most of market share in the year 2017 and was valued over USD 829.9 million. Increase in number of people suffering from end-stage heart failure will result in growing demand and adoption rate for LVAD devices, enhancing the left ventricular assist devices market growth in the near future.

Right ventricular assist devices market is estimated to grow at a robust CAGR of 10.6% in the forthcoming years. Increase in number of people suffering from acute right ventricular failure will result in boosting the demand and adoption rate, thereby augmenting business growth in the near future.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3014

Bridge-to-candidacy (BTC) therapy market held the maximum market share and was valued around at USD 316.4 million in the year 2017. Decrease in number of heart donors across the globe has resulted in people opting for ventricular assist devices, but the patients that are not listed for transplantation are provided BTC therapy. Increase in use of BTC therapy for severe heart failure patients needing ventricular assist device implantation urgently will enhance the market growth in the near future.

Destination therapy market is projected to witness considerable amount of growth at a CAGR of 10.8% during the forecast time period. Destination therapy provides long-term support to the patients and is one of the most advised therapies in the treatment of severe end-stage heart failure amongst the population. Several benefits provided such as high survival rate, better quality of life, cost-effectiveness and cost utility will be one of the major reasons for boosting the growth of ventricular assist devices market for destination therapy.

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/ventricular-assist-devices-market

Ventricular assist devices market by Product
• Left ventricular assist devices (LVADs)
• Right ventricular assist devices (RVADs)
• Biventricular assist devices (BIVADs)
• Percutaneous Ventricular Assist Devices
• Total Artificial Heart

Ventricular assist devices market by Application
• Destination therapy
• Bridge-to-candidacy (BTC) therapy
• Bridge-to-transplant (BTT) therapy
• Bridge-to-recovery (BTR) therapy

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ventricular Assist Devices Market Trend and Demands 2019 with Key Players: Terumo Medical Corporation, Medtronic, Abiomed, LivaNova here

News-ID: 1471548 • Views: 402

More Releases from Global Market Insights

Medical Tourism Market 2019| Business Scope for Forecast period 2025
Mexico medical tourism market accounted for revenue of USD 2.4 billion in 2018, owing to availability of high-quality and efficient medical treatment at significantly lower cost as compared to other developed nations. Also, the Mexican government have invested a large proportion of their GDP towards improvement of healthcare infrastructure to improve the healthcare infrastructure. Increasing number of people suffering from various chronic diseases, rising demand for advanced treatment coupled with
U.S. Home Infusion Therapy Market 2019| Industry Developments, Outlook, Current …
U.S. Home Infusion Therapy Market will exceed USD 13.5 billion by 2024; as per a new research report. Increasing rates of hospital acquired infections have impacted the market growth positively. In American hospitals, infections associated with health care account for around 1.7 million infections and 99,000 deaths every year. These infections lead to chronic diseases that require continuous monitoring; thus, accelerate demand for home infusion therapies. The U.S. home infusion therapy
Automotive Films Market to accrue lucrative gains over the forecast timeframe
North America led by Canada and the U.S. automotive films market demand may witness gains over the forecast timeframe. This can be attributed to the increase in demand for personalized vehicles and presence of key leaders is expected to have a positive impact on the market. Moreover, robust growth in construction industry is anticipated to boost market demand. Europe automotive films market demand, led by Germany, Spain, UK, France and Russia
Composites Market to depict appreciable growth prospects over 2019-2025
Based on the fibre type Composite Market size can be segmented into; carbon fibres, fiberglass, aramid fiber & others. Carbon fibres have excellent tensile strength and resistance to temperatures, these mentioned properties make it desirable for the application in the aerospace and defence sector. On the other hand, fiberglass is nonconductive but not strong as carbon fibre making it suitable for the broadcast and transmission application. Based on the resin

All 5 Releases


More Releases for Ventricular

Latest Evolution of Ventricular Drainage Sets Market Analysis 2026
Ventricular Drainage Sets Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Ventricular Drainage Sets market research report is a professional and in-depth study on the current state of Ventricular Drainage Sets Industry. The Ventricular Drainage Sets Market research report covers the present scenario and
Left Ventricular Dysfunction - Pipeline Review, H1 2018
Left Ventricular Dysfunction Overview Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and Left Ventricular Dysfunction. Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811435-left-ventricular-dysfunction-pipeline-review-h1-2018 Top Companies mentioned Bayer AG Innopharmax Inc Mesoblast Ltd Novartis AG Quantum Genomics SA TiGenix NV Left Ventricular Dysfunction Industry Major Outlook Pharmaceutical and Healthcare latest pipeline guide Left Ventricular Dysfunction -
Ventricular Tachycardia Market Forecast Report Offers Actionable Insights 2017 - …
Ventricular tachycardia is a condition, wherein the pulse rate is more than 100 beats per minute with minimum three continuous irregular heartbeats. This condition occurs in bottom chambers of the heart and develops as an early or late complication of heart attack. Patients suffering from cardiomyopathy, myocarditis, or valvular heart disease are at a higher risk of developing ventricular tachycardia. Major reasons for ventricular tachycardia are changes in pH values,
Left Ventricular Dysfunction - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2017, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape. Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and coronary artery disease. Report Highlights Publisher's Pharmaceutical and Healthcare
Ventricular Tachycardia Treatment Market And Segment Forecasts To 2017 – 2025
Ventricular tachycardia is a life threatening heart condition in which arrhythmic heart beats occur in the ventricles. The two lower chambers of the heart are known as ventricles. They are responsible for supplying the blood received from atria to different parts of the body. When a person suffers from ventricular tachycardia, a high pulse with more than 100 beats per minute is registered with minimum 3 irregular heartbeats experienced in
05-08-2017 | Health & Medicine
SA-BRC
Ventricular Assist Devices (VAD) Market Assessment
Ventricular assist devices (VAD) are mechanical pumps used to support patients with a weakened heart or in case of heart failure to temporarily maintain heart function. The devices helps in re-establishing normal hemodynamics under conditions involving damaged ventricle. Increasing trend for sedentary lifestyle, rising obesity population globally, lifestyle changes and various other factors have resulted an increase in cardiovascular disorders. This rising prevalence across the globe has been a major